Exciting development from R&D perspective for sure. Love the infusion of capital and the media buzz.
We have been tackling the opportunity of point-of-care ultrasound with a phone and tablet solution for a few years now (www.mobisante.com). There are interesting nuances related to business model, education, and market adoption even within US, and non-trivial complexity in purchasing dynamics and politics when it comes to emerging markets. These are just as important to break through as cost and complexity barriers – which we have already done to some extent.
That said, we would love to source these transducers when commercially available and cleared by the FDA, and integrate them in our solution offering!
We have been tackling the opportunity of point-of-care ultrasound with a phone and tablet solution for a few years now (www.mobisante.com). There are interesting nuances related to business model, education, and market adoption even within US, and non-trivial complexity in purchasing dynamics and politics when it comes to emerging markets. These are just as important to break through as cost and complexity barriers – which we have already done to some extent.
That said, we would love to source these transducers when commercially available and cleared by the FDA, and integrate them in our solution offering!
Sailesh Chutani, CEO Mobisante